Special Seminar with Klaus Pantel
Over the past ten years, circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) have received enormous attention as new biomarkers and subject of translational research. Join us in a Zoom webinar to hear Professor Pantel, considered as the father of the term liquid biopsy, give a talk on the application of CTCs and ctDNA in cancer research.
Speaker: Professor Klaus Pantel, Director of the Institute of Tumor Biology, Center for Experimental Medicine, UKE Hamburg.
Preliminary title: "The promise of ctDNA and CTCs in the evaluation of cancer treatment efficacy"
Time: Thursday September 29, 2022 at 12.30 - 13.30.
Where: Digital event in Zoom. Access link will be available here some days before the event.
Abstract: Will be available here.